Chair of Inorganic Chemistry I - Bioinorganic Chemistry

Reviews and highlights

• Karolina Kamińska, Andrzej Mular, Evgenia Olshvang, Nils Metzler Nolte, Henryk Kozłowski, Elżbieta Wojaczyńska and Elżbieta Gumienna-Kontecka
  The diversity and utility of arylthiazoline and aryloxazoline siderophores: challenges of total synthesis
  RSC Advances, 2022,12, 25284-25322, DOI:10.1039/d2ra03841b

• Katherine J. Franz and Nils Metzler-Nolte,
  Introduction: Metals in Medicine
  Chemical Reviews, 2019, 119(2), 727-729, DOI:10.1021/acs.chemrev.8b00685
  

• Joan Josep Soldevila-Barreda and Nils Metzler-Nolte,
  Intracellular Catalysis with Selected Metal Complexes and Metallic Nanoparticles: Advances toward the Development of Catalytic Metallodrugs
  Chemical Reviews, 2019, 119(2), 829-869, DOI:10.1021/acs.chemrev.8b00493
  

• H. Bauke Albada*, N. Metzler-Nolte*
  Highly Potent Antibacterial Organometallic Peptide Conjugates
  Acc. Chem. Res. 50 (2017) 2510–2518; DOI: 10.1021/acs.accounts.7b00282

• H. Bauke Albada*, N. Metzler-Nolte*
  Organometallic–Peptide Bioconjugates: Synthetic Strategies and Medicinal Applications
  Chem. Rev. 116 (2016) 11797 - 11839; DOI:10.1021/acs.chemrev.6b00166

• Christian G. Hartinger, Nils Metzler-Nolte and Paul J. Dyson
  Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
  Organometallics, 2012, 31 (16), 5677–5685, DOI: 10.1021/om300373t
  

• Malay Patra, Gilles Gasser and Nils Metzler-Nolte
  Small organometallic compounds as antibacterial agents
  Dalton Trans., 2012, 41, 6350-6358, DOI: 10.1039/C2DT12460B.
  

• Gilles Gasser and Nils Metzler-Nolte
  The potential of organometallic complexes in medicinal chemistry
  Curr. Op. Chem. Biol., 2012, 16, 84-91 http://dx.doi.org/10.1016/j.cbpa.2012.01.013.
  

• Gilles Gasser, Anna M. Sosniak and Nils Metzler-Nolte
  Metal-containing peptide nucleic acid conjugates
  Dalton Trans., 2011, 40, 7061-7076 DOI: 10.1039/C0DT01706J.
  First review on Metal-PNA conjugates; Cover picture of Dalton Transactions

• Gilles Gasser, Ingo Ott, and Nils Metzler-Nolte
  Organometallic Anticancer Compounds
  J. Med. Chem. (2011), 54 (1), 3–25, DOI: 10.1021/jm100020w.
  Freely available through Open Access Option


• Julia E. Bandow*, N. Metzler-Nolte*
  New ways of killing the beast: Opportunities for Inorganic-Organic hybrid materials as antibiotic drugs
  ChemBioChem 10 (2009) 2847-2850, DOI: 10.1002/cbic.200900628.
  
  
• N. Metzler-Nolte*
  Medicinal applications of metal-peptide bioconjugates
  Chimia 61 (2007) 736-741, DOI: 10.2533/chimia.2007.736.
  
  
• N. Metzler-Nolte*
  Medizinische Organometallchemie
  Nachr. Chem. 54 (2006) 966-970.
  
  
• S.I. Kirin, H.-B. Kraatz, N. Metzler-Nolte*
  Systematizing structural motifs and nomenclature in 1,n'-disubstituted ferrocene peptides
  Chem. Soc. Rev. 35 (2006) 348-354, DOI: 10.1039/B511332F.
  Cover picture of Chem. Soc. Rev.
  
  
• U. Schatzschneider, N. Metzler-Nolte*
  New emerging principles in medicinal organometallic chemistry
  Angew Chem. 118 (2006) 1534-1537; Angew. Chem. Int. Ed. 45 (2006) 1504-1507, DOI: 10.1002/anie.200504604.
  
  
• D.R. van Staveren, N. Metzler-Nolte*
  The bioorganometallic chemistry of ferrocene
  Chem. Rev. 104 (2004) 5931-5985, DOI: 10.1021/cr0101510.
  
  
• N. Metzler-Nolte*
  Labelling of biomolecules for medicinal applications - Bio-organometallics at its best
  Angew. Chem. 113 (2001) 1072-1076; Angew. Chem. Int. Ed. 40 (2001) 1040-1044, DOI: 10.1002/1521-3773(20010316)40:6<104.